← Back to signals
JNJ
STRONG BUYJohnson & Johnson
Health Care
0.53
PEGY ratio
Rank #205
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 47.5% annually over 5 years. Pays a 2.4% dividend yield.
JNJ is trading at 26.4x earnings against 47.5% growth + 2.4% yield, giving a PEGY of 0.53. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-04-24
Valuation
26.4x
P/E Ratio
Growth
47.5%
5yr EPS
Income
2.4%
Div Yield
PEGY Components
PEGY Score0.53
Denominator49.8%
EPS (TTM)$8.62
Market Data
Price$227.50
ExchangeNYSE
S&P 500Dow 30
What Changed
PEGY Score
1.22→0.53(-0.69)
Zone
Hold→Strong Buy
Rank
#279→#205(+74 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only